Safer Drugs By Design

EligoChem Ltd design, synthesise and procure unique amphiphilic compound libraries for use in drug discovery.

These small molecule, drug-like compounds have been selected for their amphiphilic properties that will demonstrate atypically good absorption and provide access to new drug and target space while reducing poly-pharmacology and attrition risk compared to most available library compounds.

We also collaborate with universities and research organisations to screen compounds and engage in lead identification and optimisation implementing the EligoChem technology.

Our experienced team also provide medicinal and computational chemistry consultancy services to enable the optimisation and diversification of your leads utilising the EligoChem lead hopping technology.

Please contact us  to discuss potential collaboration.